Strides Arcolab Bangalore plant gets USFDA approval

New Delhi, Mar 12 (UNI) Strides Arcolab Ltd today said its penicillin sterile manufacturing site in Bangalore has been classified as acceptable by the USFDA for manufacturing sterile products for the US market.

In a statement, company Vice Chairman and Group CEO Arun Kumar said the USFDA approval of the penicillin sterile facility is an important milestone for its US strategy and will support important product submissions with the FDA.

The penicillin sterile facility in Bangalore manufactures sterile injectables in dry powder vials. The plant supports important current and future submissions for the US market.

UNI PBB PDT RS1536